ity, positive predictive value, and negative predictive value in as little as 5 l of patient serum (18) .
The simultaneous detection of all three immunoglobulin isotypes, IgG, IgM, and IgA, should offer a more complete picture of the infection status of the patient. Together, these three antibody isotypes could provide information regarding seroconversion and whether the infection is acute, chronic, or reactivated. With the exception of the BioPlex 2200 (which does not measure IgA), all currently available tests would have to be run individually, thus requiring significantly larger serum sample volumes (5 to 50 l for plasmonic gold chip-and bead-based assays versus Ն100 l for ELISA and other assays) and an increase in reagents and labor. One solution to this problem would be to perform these assays in a multiplex format where the three antibody isotypes are measured simultaneously by using a much smaller sample volume than traditional methods. The utility and benefits of multiplex immunoassays have been widely published. There are multiple reports of serological multiplex immunoassays for the measurement of antibodies to a wide range of pathogens, including T. gondii, Escherichia coli O157:H7, Helicobacter pylori, HIV, and noroviruses (19) (20) (21) . However, multiplex immunoassays also present challenges and limitations that include cross-reactivity and assay sensitivity and specificity that must be addressed before they can be used as definitive diagnostic tools (22) .
Major hurdles confronting the development of antibody screening tools include the use of invasive procedures, the need for trained personnel, and the costs involved in blood collection. To overcome these hurdles, research laboratories have been studying the efficacy of replacing serum with saliva as the diagnostic fluid of choice for measuring immune responses to pathogen exposure. Saliva collection is noninvasive and easy to perform and requires minimal training. Moreover, saliva has been shown to be an ideal matrix for exposure and infection studies, as demonstrated by the numerous reports of very good correlation of antibody responses in paired serum and saliva samples (23) (24) (25) (26) . The combination of speed and the ability of multiplex immunoassays to measure multiple analytes simultaneously in very small sample volumes with the use of an easily collected noninvasive matrix like saliva may potentially have a significant positive impact on the ability to provide universal screening for not only T. gondii infection but also for a host of other infections.
In summary, the application of multiplex immunoassay technologies such as the plasmonic gold chip assay along with less invasive sample collection procedures for the measurement of antibodies against T. gondii and other infectious microorganisms may provide more sensitive and specific tools to better implement routine screening for various infections and autoimmune disorders.
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